Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Pacific Edge named Top Bioscience Company in 2014

Pacific Edge named Top Bioscience Company in 2014


Pacific Edge has been named NZBIO’s top bioscience company for 2014. Pacific Edge was specifically recognised for building the profile and credibility of biotechnology and biotechnology companies in New Zealand.

The announcement of the industry accolade this week is further recognition for the Dunedin based cancer diagnostic company and comes a few months after taking the Supreme Award at the NZ Innovation Council Awards.

Pacific Edge Chief Executive Office David Darling says the Company is delighted to receive the recognition for the advances being made to the clinical capability for the detection and management of cancers. The company’s Urine Sampling System is becoming a core element of the advances in clinical utility, which can be used by the patient in-home to take a sample.

“It is rare in the biotechnology sector to have a company with the capability and resources to go from discovery science all the way through clinical trials and product development to finally making a commercial product as Pacific Edge has done with Cxbladder – our molecular diagnostic test for bladder cancer.”

Cxbladder is a non-invasive test with the Company’s easy to use Urine Sampling System becoming a core element of the advances in clinical utility, which allows patients can use at home. The sample is analysed in one of Pacific Edge’s laboratories for the tell-tale molecular markers that will provide the urologist with information on the probability of the patient having bladder cancer, or not.

Cxbladder is now available commercially in the United States through the company’s own CLIA and CAP regulated laboratory in Hershey, Pennsylvania. In the later part of 2013 the company signed three large, preferred national provider networks. These provider networks provide patients access to healthcare services and technology by contracting with providers and payers on a national basis. These three agreements signed with FedMed, ACPN and Stratose give millions of Americans access to Cxbladder and its positive benefits as a quick, cost effective, non-invasive and highly accurate cancer detection test that is particularly appealing to US healthcare professionals, patients, and insurers.

The custom built, commercial laboratory for Pacific Edge’s US subsidiary PEDUSA was completed in September 2012 to process Cxbladder samples, was certified in 2013 by CLIA and more recently by CAP, to enable the laboratory to offer Cxbladder as a Laboratory Developed Test (LDT) to clinicians and physicians.

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

ETS Review: Modelling Documents Released

Three technical documents are being released to help New Zealanders engage with the Emissions Trading Scheme (ETS) review, Climate Change Minister Paula Bennett says. More>>

ALSO:

Northland: Govt Plan Targets Transport, Web, Maori Assets

The government has released a 10-year plan to attract investors and lift economic growth in Northland, a region that perennially underperforms the rest of the country even while being endowed with natural beauty, productive land, minerals, a potential workforce, scope for manufacturing, forestry and aquaculture, and proximity to Auckland. More>>

ALSO:

Statistics: Unemployment Rate Falls To 5.3 Percent

The unemployment rate fell to 5.3 percent in the December 2015 quarter (from 6.0 percent), Statistics New Zealand said today. This is the lowest unemployment rate since March 2009. There were 16,000 fewer people unemployed than in the September ... More>>

ALSO:

Employment: Labour Urges Talley’s To End AFFCO Lockout

Labour has urged Talley’s to resolve the ongoing industrial dispute with AFFCO workers which is having a severe effect on the employees, their families and their communities, Labour’s Workplace Relations spokesperson Iain Lees-Galloway says. More>>

ALSO:

Three Kings: Govt To Oppose Appeal Blocking $1.2B Auckland Housing Plan

Environment Minister Nick Smith and Housing New Zealand have joined legal proceedings in support of Auckland Council and Fletcher Building opposing a bid by community groups to only allow low-rise housing in a $1.2 billion housing redevelopment on the disused site of the Three Kings quarry. More>>

ALSO:

Transport: Jetstar Expands Regional Network With Three New Routes

More New Zealanders than ever before will have access to Jetstar’s affordable flights when new services take off today from Auckland to New Plymouth and Palmerston North, and Nelson to Wellington. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news